Shear-induced platelet activation and platelet microparticle formation at blood flow conditions as in arteries with a severe stenosis.

In the present study, we investigated whether high arterial shear stresses at various exposure times or a sudden increase in shear stress introduced by a stenosis affect platelet activation and platelet microparticle formation in native human blood. We used a parallel-plate perfusion chamber device through which nonanticoagulated human blood was drawn (10 mL/min) by a pump directly from an antecubital vein through the flow channel of a perfusion chamber at wall shear rates of 420, 2600, and 10500 s-1. In another set of experiments, an eccentric stenosis was introduced into the flow channel. Wall shear rates of 2600 or 10500 s-1 at the stenosis apex were maintained at the same flow rate. The wall shear rate upstream and downstream of these stenoses was 420 s-1. A shear rate of 420 s-1 is within the range of those encountered in healthy small coronary arteries, whereas those of 2600 and 10500 s-1 are representative for vessels with various degrees of stenotic lesions. The blood was exposed to these shear rates for periods varying from 0.075 to 3.045 seconds. Platelet activation was assessed as activated glycoprotein (GP) IIb/IIIa by FITC-labeled monoclonal antibody (MAb) PAC-1 and aminophospholipid translocation by FITC-labeled annexin V. Microparticle formation was quantified by FITC-labeled MAb Y2/51 directed against GP IIIa. Significant platelet activation and formation of microparticles were observed at 10500 s-1 only (P < .008). This shear-induced platelet activation and microparticle formation were enhanced by introduction of a thrombus-promoting surface consisting of type III human collagen fibrils. Introduction of the most severe stenosis at 10500 s-1 further increased platelet activation (P < .017). The collagen-induced thrombus formation increased the platelet thrombus volume at 10500 s-1 from 16.5 to 33.8 microns3/microns2 (P < .003) on the stenosis apex when the most severe stenosis was used. A correlation (P < .0001) between platelet thrombus volume and platelet microparticle formation was observed in the presence of the eccentric stenoses. Apparently, high shear stress (315 dynes/cm2 at 10500 s-1), as encountered in severe atherosclerotic arteries, activated platelets and triggered platelet microparticle formation. In contrast, no significant platelet activation or formation of platelet microparticles was observed at physiological shear (420 s-1) or at the shear condition simulating shear in arteries with a less severe stenosis (2600 s-1). The data imply that platelets are activated and form microparticles in native blood at very high shear stresses. These events are potentiated by prolonged exposure to the high shear or by a sudden change of increasing shear due to the stenosis. The latter situation apparently enhances platelet thrombus formation at the stenosis.

[1]  G. Tjønnfjord,et al.  Reduced Effect of Aspirin on Thrombus Formation at High Shear and Disturbed Laminar Blood Flow , 1996, Thrombosis and Haemostasis.

[2]  P. Kierulf,et al.  Collagen Induced Thrombus Formation at the Apex of Eccentric Stenoses - A Time Course Study with Non-Anticoagulated Human Blood , 1996, Thrombosis and Haemostasis.

[3]  T. Lindahl,et al.  Stimulated Glanzmann's thrombasthenia platelets produced microvesicles. Microvesiculation correlates better to exposure of procoagulant surface than to activation of GPIIb-IIIa. , 1995, Thrombosis and haemostasis.

[4]  P. Holme,et al.  Platelet‐derived microvesicles and activated platelets express factor Xa activity , 1995, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[5]  K. Sakariassen,et al.  A perfusion chamber developed to investigate thrombus formation and shear profiles in flowing native human blood at the apex of well-defined stenoses. , 1994, Arteriosclerosis and Thrombosis A Journal of Vascular Biology.

[6]  M. Abdelnoor,et al.  Demonstration of Platelet-Derived Microvesicles in Blood from Patients with Activated Coagulation and Fibrinolysis Using a Filtration Technique and Western Blotting , 1994, Thrombosis and Haemostasis.

[7]  B. Boneu,et al.  Effect of blood flow on thrombin generation is dependent on the nature of the thrombogenic surface , 1994 .

[8]  P. Kierulf,et al.  Modulation of thrombotic responses in moderately stenosed arteries by cigarette smoking and aspirin ingestion. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[9]  D. Williams,et al.  Granule secretion markers on fluid-phase platelets in whole blood perfused through capillary tubing. , 1994, Journal of biomedical materials research.

[10]  C. Werter,et al.  Culprit lesion morphology and stenosis severity in the prediction of reocclusion after coronary thrombolysis: angiographic results of the APRICOT study. Antithrombotics in the Prevention of Reocclusion in Coronary Thrombolysis. , 1993, Journal of the American College of Cardiology.

[11]  A. Beaudoin,et al.  Analysis of shear stress and hemodynamic factors in a model of coronary artery stenosis and thrombosis. , 1993, The American journal of physiology.

[12]  P. Holme,et al.  The Difference Between Platelet and Plasma FXIII Used to Study the Mechanism of Platelet Microvesicle Formation , 1993, Thrombosis and Haemostasis.

[13]  Sakariassen Ks,et al.  Mechanisms of thromboembolism at arterial plaques. , 1993 .

[14]  M. Sefton,et al.  Platelet-derived microparticle formation involves glycoprotein IIb-IIIa. Inhibition by RGDS and a Glanzmann's thrombasthenia defect. , 1993, The Journal of biological chemistry.

[15]  A. Nurden,et al.  Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: a flow cytometry study showing a role for free sulfhydryl groups , 1993 .

[16]  L. Horstman,et al.  Clinical significance of platelet microparticles in autoimmune thrombocytopenias. , 1992, The Journal of laboratory and clinical medicine.

[17]  V. Turitto,et al.  Effect of aspirin and epinephrine on experimentally induced thrombogenesis in dogs. A parallelism between in vivo and ex vivo thrombosis models. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[18]  P. Tracy,et al.  Functional characterization of human platelet-released factor V and its activation by factor Xa and thrombin. , 1990, The Journal of biological chemistry.

[19]  A. Schroit,et al.  Loss of membrane phospholipid asymmetry in platelets and red cells may be associated with calcium-induced shedding of plasma membrane and inhibition of aminophospholipid translocase. , 1990, Biochimica et biophysica acta.

[20]  H C Hemker,et al.  Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers. , 1990, The Journal of biological chemistry.

[21]  H. Baumgartner,et al.  Collagen type III induced ex vivo thrombogenesis in humans. Role of platelets and leukocytes in deposition of fibrin. , 1990, Arteriosclerosis.

[22]  P. Sims,et al.  Role of calcium and calpain in complement-induced vesiculation of the platelet plasma membrane and in the exposure of the platelet factor Va receptor. , 1990, Biochemistry.

[23]  C. Esmon,et al.  Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity. , 1989, The Journal of biological chemistry.

[24]  J. Badimón,et al.  Mechanisms of arterial thrombosis in nonparallel streamlines: platelet thrombi grow on the apex of stenotic severely injured vessel wall. Experimental study in the pig model. , 1989, The Journal of clinical investigation.

[25]  K. Fujikawa,et al.  Phospholipid binding properties of human placental anticoagulant protein-I, a member of the lipocortin family. , 1989, The Journal of biological chemistry.

[26]  H. Baumgartner,et al.  Growth and Stability of Thrombi in Flowing Citrated Blood: Assessment of Platelet-Surface Interactions with Computer-Assisted Morphometry , 1988, Thrombosis and Haemostasis.

[27]  P. Sims,et al.  Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. , 1988, The Journal of biological chemistry.

[28]  J. O'brien,et al.  Shear stress activation of platelet glycoprotein IIb/IIIa plus von Willebrand factor causes aggregation: filter blockage and the long bleeding time in von Willebrand's disease , 1987 .

[29]  J. George,et al.  Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery. , 1986, The Journal of clinical investigation.

[30]  H. Goldsmith,et al.  Rheological Aspects of Thrombosis and Haemostasis: Basic Principles and Applications , 1986, Thrombosis and Haemostasis.

[31]  M. Blombäck,et al.  Studies on blood coagulation activity during storage of red cell products intended for transfusion. , 1985, Thrombosis research.

[32]  J. Hoxie,et al.  Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation. , 1985, The Journal of biological chemistry.

[33]  H Schmid-Schönbein,et al.  Platelet and Coagulation Parameters Following Millisecond Exposure to Laminar Shear Stress , 1985, Thrombosis and Haemostasis.

[34]  B. Lentz,et al.  Expression of coagulant activity in human platelets: release of membranous vesicles providing platelet factor 1 and platelet factor 3. , 1985, Thrombosis research.

[35]  B. Lentz,et al.  Association of factor V activity with membranous vesicles released from human platelets: requirement for platelet stimulation. , 1985, Thrombosis research.

[36]  J. Sixma,et al.  A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix, and purified components. , 1983, The Journal of laboratory and clinical medicine.

[37]  J. Joist,et al.  Role of cytoplasmic and releasable ADP in platelet aggregation induced by laminar shear stress. , 1983, The Journal of laboratory and clinical medicine.

[38]  J. Moake,et al.  The effect of PGI2 and theophylline on the response of platelets subjected to shear stress , 1981 .

[39]  J. Goding Conjugation of antibodies with fluorochromes: modifications to the standard methods. , 1976, Journal of immunological methods.

[40]  S. Karpatkin,et al.  Microthrombocytosis and Platelet Fragmentation Associated with Idiopathic/Autoimmune Thrombocytopenic Purpura , 1975, British journal of haematology.

[41]  K. Konstantopoulos,et al.  Flow cytometric studies of platelet responses to shear stress in whole blood. , 1995, Biorheology.

[42]  N. Hwang,et al.  Advances in Cardiovascular Engineering , 1992, NATO ASI Series.

[43]  K. Sakariassen,et al.  Ex Vivo Models for Studying Thrombosis: Special Emphasis on Shear Rate Dependent Blood-Collagen Interactions , 1992 .

[44]  C. Abrams,et al.  Direct detection of activated platelets and platelet-derived microparticles in humans. , 1990, Blood.

[45]  H. Baumgartner,et al.  Measurements of platelet interaction with components of the vessel wall in flowing blood. , 1989, Methods in enzymology.

[46]  E. J. Miller,et al.  Preparation and characterization of the different types of collagen. , 1982, Methods in enzymology.